Mark Kei Wei Leong
CIK: 0001973389
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GDTC
CytoMed Therapeutics Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Leong Mark Kei Wei
Leong Mark Kei Wei (SEC CIK 0001973389) files insider reports with the SEC as Director of CytoMed Therapeutics Ltd (GDTC).
Signal8 holds 1 ownership filing by Leong Mark Kei Wei, a Form 3, filed on May 15, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Leong Mark Kei Wei's filings is in SINGAPORE.
Other insiders filing for CytoMed Therapeutics Ltd (GDTC)
- Choo Chee Kong, Director
- Toh Keng Kiat, Director
- Yew Chak Hua, Director
- TAN YOONG YING, Chief Corporate Officer
- Goh Yvonne, Chief Financial Officer